Abstract:Background Umbilical cord (UC)-derived mesenchymal stem cells (MSCs) have been confirmed to exert therapeutic effects on systemic lupus erythematosus (SLE). Deficiency in SLE macrophages exhibits excessive activation and inefficient clearance of self nuclear antigens. However, whether the benefit effect of UCMSCs on SLE was mediated by regulatory effects on macrophages remains to be elucidated. Objectives We aim to explore whether UCMSCs could educate SLE macrophage to become a kind of alternatively activated macrophage and increase its phagocytic activity. Methods UCMSCs were injected into B6.MRL-Faslpr mice. The therapeutic effects of MSCs transplantation were evaluated by the renal pathology, proteinuria, spleen index, T lymphocyte subpopulation and plasma cells. Murine peritoneal/renal macrophages were isolated to detect the proportion of alternatively activated macrophage (F4/80+CD206+). To determine the phagocytic activity of murine peritoneal/renal macrophages, FITC-labeled flurospheres were added into the cultures. The uptake of FITC-labeled flurospheres was determined by flow cytometry. CD14+ monocytes were isolated from peripheral blood of healthy donors (HC) and SLE patients. We cultured human monocytes for 7 days with macrophage colony-stimulating factor (M-CSF) to generate macrophages, and then cocultured them for 2 more days with UCMSCs in a transwell culture system. The levels of CD206 and phagocytic activity of macrophages were detected by flow cytometry. Results Compared with C57BL/6 mice, B6.MRL-Faslpr mice macrophages exhibited lower level of CD206, the marker of alternatively activated macrophages. In addition, the phagocytic activity of B6.MRL-Faslpr mice macrophages was also decreased. UCMSCs transplantation could rescue both the proportion of CD206+ macrophages and the phagocytic activity. Interestingly, the proportion of CD206+ macrophages was positively correlated with the phagocytic activity. Similar to the lupus mice, macrophages from SLE patients showed lower expression of CD206 and phagocytic activity. SLE macrophages cocultured with UCMSCs consistently increased the expression of CD206 and phagocytic activity. In addition, the up-regulation of phagocytic activity by UCMSCs was only appeared in CD206+ macrophages. This phenomenon was also observed in UCMSCs transplanted SLE patients. Furthermore, the addition of specific neutralizing antibodies/inhibitor/siRNA of HGF, TGFβ1, PGE2 and HO-1 could not reverse the effects of UCMSCs on SLE macrophages. Conclusions UCMSCs could alleviate SLE through promoting the generation of CD206+ macrophage and increasing its phagocytic activity, and these effects was independent of HGF, TGFβ1, PGE2 and HO-1. Disclosure of Interest None declared

USP18 induction regulates immunometabolism to attenuate M1 signal-polarized macrophages and enhance IL-4-polarized macrophages in systemic lupus erythematosus

USP19 Suppresses Inflammation and Promotes M2-like Macrophage Polarization by Manipulating NLRP3 Function Via Autophagy

A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects Against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice.

Macrophage Differentiation and Polarization Via Phosphatidylinositol 3-Kinase/akt-erk Signaling Pathway Conferred by Serum Amyloid P Component

Novel Mitophagy Inducer Alleviates Lupus Nephritis by Reducing Myeloid Cell Activation and Autoantigen Presentation.

IRF-8/miR-451a regulates M-MDSC differentiation via the AMPK/mTOR signal pathway during lupus development

Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus

A Tissue-Tended Mycophenolate-Modified Nanoparticle Alleviates Systemic Lupus Erythematosus in MRL/Lpr Mouse Model Mainly by Promoting Local M2-Like Macrophagocytes Polarization

MicroRNA-98-5p Inhibits IFI44L-Mediated Differentiation of Dendritic Cells and Activation of Interferon Pathway in Systemic Lupus Erythematosus

SMURF1 inhibits the Th17 and Th17.1 polarization and improves the Treg/Th17 imbalance in systemic lupus erythematosus through the ubiquitination of RORγt

Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus

Blockade of Macrophage Autophagy Ameliorates Activated Lymphocytes-Derived DNA Induced Murine Lupus Possibly Via Inhibition of Proinflammatory Cytokine Production.

AB0179 Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus

Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications

Effects of Systemic Lupus Erythematosus Susceptible Gene IFIT1 on Chemokine Expression in Mouse Macrophage Cells

Ubiquitin‑specific Protease 8 Ameliorates Lipopolysaccharide‑induced Spleen Injury Via Suppression of NF‑κB and MAPK Signaling Pathways

Macrophage Migration Inhibitory Factor deficiency attenuates kidney Injury by downregulating cytokines via CYR61 in lupus-prone mice induced by pristane.

Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell

MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) Polymerase-1 in patients with systemic lupus erythematosus

Inositol‐Requiring Enzyme 1α–mediated Synthesis of Monounsaturated Fatty Acids As a Driver of B Cell Differentiation and Lupus‐like Autoimmune Disease

FoxO1 Deficiency in Monocytic Myeloid-Derived Suppressor Cells Exacerbates B Cell Dysfunction in Systemic Lupus Erythematosus.